Veterinary Diagnostics Market Size & Share 2026-2035

Veterinary Diagnostics Market Analysis

Based on the product, the veterinary diagnostics market is segmented into consumables, instruments and software. The consumables segment has asserted its dominance in the market by securing a significant market share of 51.3% in 2025 owing to its wide usage in the veterinary field and recurring revenue model, growing at a CAGR of 9.2% during the forecast period.

• Consumables represent the largest revenue-generating category due to their recurring usage across virtually all diagnostic procedures. The segment includes reagents, diagnostic test kits, assay cartridges, blood collection tubes, slides, controls, and calibration materials that are routinely utilized in veterinary clinics, hospitals, reference laboratories, and research facilities.
• The increasing volume of diagnostic testing, coupled with the growing adoption of preventive healthcare and disease screening programs, continues to drive demand for consumables. Furthermore, the expansion of point-of-care (POC) diagnostics has strengthened recurring demand, as many rapid diagnostic platforms rely on single-use cartridges and test kits.
• As veterinary practices increasingly adopt advanced molecular, immunodiagnostic, and clinical chemistry tests, the need for specialized reagents and assay consumables is expected to rise, supporting long-term segment growth.
• The instruments segment accounted for a substantial share of the market in 2025 and is anticipated to grow at a CAGR of 8.7% during the forecast period. Growth is driven by increasing deployment of automated analyzers, molecular diagnostic platforms, imaging systems, and integrated laboratory equipment across veterinary healthcare settings. Continuous technological advancements aimed at improving diagnostic speed, throughput, and accuracy are further supporting demand.
• The software segment is projected to witness the fastest growth, registering a CAGR of 9.7% over the forecast period. Adoption of laboratory information management systems (LIMS), cloud-based diagnostic platforms, telehealth integration, and AI-powered diagnostic tools is enabling more efficient data management, workflow automation, and clinical decision-making across veterinary practices.

Based on modality, the veterinary diagnostics market is divided into point-of-care testing (POC) and lab-based testing. The lab-based testing segment dominated the market and is expected to reach USD 7.1 billion within the forecast period.

• Laboratory-based testing remains the preferred diagnostic approach for comprehensive disease evaluation due to its ability to perform advanced molecular diagnostics, microbiology testing, immunoassays, toxicology assessments, and specialized pathology examinations. These tests often require sophisticated instrumentation, highly trained personnel, and controlled laboratory environments.
• The segment benefits from the presence of established veterinary reference laboratory networks, particularly in developed markets where centralized testing facilities offer high-throughput capabilities and specialized diagnostic services. Reference laboratories continue to play a critical role in confirmatory testing, disease surveillance, epidemiological monitoring, and complex case management.
• Laboratory diagnostics are generally regarded as the gold standard for accuracy, sensitivity, and reproducibility, making them indispensable for detecting infectious diseases, chronic conditions, and emerging zoonotic threats.
• The point-of-care testing segment accounted for significant revenue in 2025 and is expected to expand at a CAGR of 9.2% during the forecast period. Growth is fueled by increasing demand for rapid diagnostic results within veterinary clinics and hospitals. POC testing enables immediate clinical decision-making, faster treatment initiation, and improved patient management, particularly in emergency and outpatient settings.

Based on technology, the veterinary diagnostics market is divided into clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, and other technologies. The clinical biochemistry segment dominated the market in 2025 with a market share of 25.6%.

• Clinical biochemistry plays a fundamental role in veterinary diagnostics by assessing organ function, metabolic health, and physiological abnormalities through the analysis of blood, urine, and other biological samples. These tests are routinely used to diagnose and monitor conditions affecting the liver, kidneys, endocrine system, and metabolism.
• The increasing prevalence of chronic diseases among companion animals, including diabetes, obesity, renal disease, and endocrine disorders, continues to drive demand for clinical chemistry testing. Routine wellness examinations and preventive screening programs are also contributing to higher testing volumes.
• Rising pet ownership, increasing expenditure on animal healthcare, and growing awareness regarding preventive medicine have further strengthened demand for clinical biochemistry analyzers and associated consumables, reinforcing the segment’s market leadership.
• The immunodiagnostics segment accounted for a substantial share of market revenue in 2025 and is projected to grow at a CAGR of 8.8%. Growth is supported by the widespread use of enzyme-linked immunosorbent assays (ELISA), rapid antigen tests, and lateral flow assays for the detection of infectious diseases, hormones, and biomarkers. The technology's cost-effectiveness, ease of use, and rapid turnaround time continue to drive adoption.
• Molecular diagnostics is expected to be one of the fastest-growing technology segments, expanding at a CAGR of 9.6% during the forecast period. The increasing adoption of polymerase chain reaction (PCR), real-time PCR, sequencing technologies, and other genomic tools is enhancing the accuracy and speed of disease detection. These technologies are becoming increasingly important for identifying emerging pathogens, antimicrobial resistance markers, and zoonotic diseases.
• The hematology segment is anticipated to grow at a CAGR of 8.6%, supported by the routine use of complete blood count (CBC) testing for evaluating infections, inflammatory conditions, anemia, immune disorders, and overall animal health status. Hematology remains a core component of veterinary diagnostic workflows due to its clinical utility and broad application across animal species.

Based on the application, the veterinary diagnostics market is segmented into bacteriology, pathology, parasitology, and other applications. The bacteriology segment dominated in 2025 and is anticipated to grow at a CAGR of 8.9% during the forecast period.

• Bacteriology remains a cornerstone of veterinary diagnostics due to its critical role in identifying bacterial pathogens responsible for infectious diseases in companion and livestock animals. Early and accurate pathogen identification is essential for disease management, outbreak control, and antimicrobial stewardship programs.
• The high prevalence of bacterial diseases such as bovine tuberculosis, brucellosis, salmonellosis, mastitis, anthrax, and respiratory infections continues to generate strong demand for bacteriological testing across veterinary healthcare settings.
• Advances in culture techniques, automated microbial identification systems, antimicrobial susceptibility testing, rapid antigen detection methods, and molecular-based pathogen identification have significantly improved diagnostic efficiency and accuracy.
• Growing investments in veterinary laboratory infrastructure, disease surveillance programs, and livestock health management initiatives are further strengthening the position of bacteriology within the veterinary diagnostics industry.
• The pathology segment accounted for significant revenue in 2025 and is projected to expand at a CAGR of 9.2% over the forecast period. Increasing utilization of histopathology, cytopathology, and tissue-based diagnostics for cancer detection, inflammatory disorders, infectious diseases, and organ dysfunction is supporting segment growth. The rising incidence of oncology cases among companion animals is expected to further increase demand for pathology services.

Based on animal type, the veterinary diagnostics market is categorized into companion animals and farm animals. The companion animal segment dominated the market in 2025 and accounted for USD 4.1 billion. The segment includes dogs, cats, horses, and other companion animals.

• The companion animal segment includes dogs, cats, horses, and other pets and represents the largest market share due to increasing pet ownership, growing humanization of pets, and rising expenditure on animal healthcare. Pet owners are increasingly seeking advanced diagnostic services to improve disease prevention, treatment outcomes, and overall quality of life for their animals.
• The global companion animal population continues to expand, creating sustained demand for routine wellness testing, disease screening, and chronic disease management. Increased spending on preventive healthcare, specialty veterinary services, and pet insurance is further supporting market growth.
• The growing burden of chronic and age-related diseases among companion animals is another major driver. Conditions such as cancer, diabetes, cardiovascular disorders, kidney disease, and endocrine abnormalities require frequent diagnostic monitoring, resulting in higher utilization of veterinary diagnostic services.
• Advances in veterinary oncology, precision medicine, and molecular diagnostics are also improving disease detection capabilities, contributing to greater adoption of advanced testing solutions in companion animal healthcare.
• The farm animal segment is expected to grow at a CAGR of 9.3% during the forecast period. Growth is driven by increasing emphasis on livestock health management, disease surveillance, productivity enhancement, and food safety.
• Rising incidence of zoonotic, transboundary, and foodborne diseases has intensified the need for routine monitoring and early disease detection across cattle, poultry, swine, sheep, and other production animals. Government-led disease control programs, biosecurity initiatives, and livestock productivity improvement strategies are further accelerating the adoption of veterinary diagnostic technologies within commercial farming operations.
• As global demand for animal-derived food products continues to increase, producers are investing in advanced diagnostic tools to improve herd health, reduce economic losses from disease outbreaks, and ensure compliance with food safety and animal welfare standards.

Based on the end use, the veterinary diagnostics market is categorized into veterinary hospitals and clinics, reference/diagnostic labs, home care settings, and other end users. The veterinary hospitals and clinics segment dominated the market in 2025 with a market share of 48.1%.

• Veterinary hospitals and clinics represent the primary point of care for animal health services and generate the highest volume of diagnostic testing globally. Routine wellness examinations, disease screening, preventive healthcare assessments, and follow-up monitoring are predominantly conducted within these settings, driving substantial demand for diagnostic consumables, analyzers, and imaging systems.
• The growing population of companion animals, coupled with increasing veterinary visitation rates and higher expenditure on pet healthcare, continues to support segment growth. Veterinary practices are increasingly adopting advanced in-house diagnostic capabilities to improve workflow efficiency and enhance patient outcomes.
• The widespread adoption of point-of-care (POC) diagnostic technologies, including rapid test kits, hematology analyzers, clinical chemistry systems, and molecular diagnostic platforms, enables veterinarians to obtain real-time results and make immediate treatment decisions. This trend is strengthening the role of veterinary clinics as key diagnostic centers within the animal healthcare ecosystem.
• The reference and diagnostic laboratories segment accounted for a significant share of market revenue in 2025 and is expected to grow at a CAGR of 9.3% during the forecast period. Growth is driven by rising demand for specialized, high-complexity testing services such as molecular diagnostics, microbiology, histopathology, toxicology, and genetic testing. Increasing outsourcing of advanced diagnostic procedures by veterinary clinics to centralized laboratories is further supporting market expansion.
• The home care settings segment is projected to grow at a CAGR of 9.5% over the forecast period. Increasing availability of portable diagnostic devices, user-friendly test kits, and digital pet health monitoring solutions is encouraging at-home disease monitoring and preventive healthcare. Growing pet owner awareness regarding early disease detection and chronic disease management is expected to further accelerate adoption in this segment.

North America Veterinary Diagnostics Market

The North America dominated the veterinary diagnostics industry with a highest market share of 46.5% in 2025.

• The region benefits from a highly developed veterinary healthcare infrastructure, high pet ownership rates, advanced diagnostic capabilities, and strong adoption of innovative animal healthcare technologies. The presence of leading diagnostic companies, extensive laboratory networks, and well-established veterinary care systems continues to strengthen market growth.
• The U.S. veterinary diagnostics market reaching USD 2.2 billion in 2025 after growing from USD 2.1 billion in 2024. The country remains the largest contributor to regional revenue due to its substantial companion animal population and high veterinary healthcare expenditure.
• According to the American Veterinary Medical Association (AVMA), approximately 45.5% of U.S. households own dogs and 32.1% own cats, representing a companion animal population exceeding 160 million. This large pet base drives strong demand for routine health screenings, preventive diagnostics, chronic disease monitoring, and advanced laboratory testing.
• In addition, growing adoption of pet insurance, increasing awareness regarding preventive animal healthcare, and continuous technological advancements in molecular diagnostics, imaging, and point-of-care testing are supporting sustained market expansion across North America.

Europe Veterinary Diagnostics Market

Europe market accounted for USD 1.2 billion in 2025 and is anticipated to show considerable growth over the forecast period.

• Market growth is driven by increasing pet ownership, rising awareness of animal health and welfare, and strong government initiatives aimed at improving disease surveillance and livestock health management. The region benefits from a mature veterinary healthcare infrastructure and widespread adoption of advanced diagnostic technologies.
• Europe is home to one of the world's largest pet populations. According to industry estimates, approximately 139 million European households own at least one pet, accounting for nearly 299 million companion animals. This expanding pet population continues to generate significant demand for veterinary diagnostic services and preventive healthcare solutions.
• Countries such as Germany, France, and the UK maintain highly developed livestock industries supported by stringent disease control and animal welfare regulations. The European Union's emphasis on food safety, traceability, and animal health certification is driving increased adoption of molecular diagnostics, immunodiagnostics, and disease surveillance programs across livestock operations.
• Furthermore, ongoing advancements in veterinary medicine, coupled with the introduction of innovative diagnostic platforms and laboratory services, are expected to support long-term market growth across the region.

Asia Pacific Veterinary Diagnostics Market

The Asia Pacific veterinary diagnostics industry is anticipated to grow at the highest CAGR of 9.5% during the analysis timeframe.

• The region's growth is primarily driven by its large livestock population, increasing demand for animal-derived protein products, expanding companion animal ownership, and improving access to veterinary healthcare services. Rapid economic development and rising disposable incomes are further contributing to increased spending on animal health.
• Asia Pacific accounts for a substantial share of the global livestock and poultry population, creating significant demand for disease surveillance, outbreak prevention, and productivity management solutions. As commercial livestock farming continues to expand, producers are increasingly adopting diagnostic technologies to improve herd health and minimize economic losses.
• Governments across the region are investing heavily in veterinary infrastructure, disease control programs, and food safety initiatives. In parallel, the number of veterinary hospitals, clinics, and diagnostic laboratories continues to increase, improving access to diagnostic testing services.
• Frequent outbreaks of zoonotic and transboundary animal diseases have highlighted the importance of early disease detection and monitoring, further accelerating the adoption of advanced diagnostic solutions throughout the region.

Latin America Veterinary Diagnostics Market

The Latin America veterinary diagnostics industry is experiencing robust growth over the analysis timeframe.

• The region is characterized by a strong livestock sector and a rapidly growing companion animal population. Countries such as Brazil and Mexico are among the world's leading producers and exporters of meat and poultry products, necessitating rigorous disease surveillance and quality assurance programs.
• Diagnostic testing plays a critical role in maintaining animal health standards, supporting export requirements, and ensuring compliance with international food safety regulations. Growing investments in livestock disease management and biosecurity initiatives are driving demand for advanced diagnostic solutions.
• Brazil represents one of the most attractive markets in the region due to its large companion animal population and well-established animal production industry. Increasing pet ownership, expanding veterinary healthcare services, and rising awareness regarding preventive animal care are further supporting market growth.
• Additionally, government initiatives aimed at improving animal health outcomes, controlling zoonotic diseases, and enhancing agricultural productivity continue to create favorable opportunities for diagnostic technology adoption across Latin America.

Middle East and Africa Veterinary Diagnostics Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• Market growth is supported by increasing government investments in veterinary healthcare infrastructure, livestock development programs, and food security initiatives. Several countries in the region are strengthening animal health surveillance systems to improve domestic livestock production and reduce dependence on imported food products.
• In the Middle East, countries such as Saudi Arabia and the UAE are investing in modern veterinary facilities, disease monitoring programs, and advanced animal health technologies to support growing agricultural and livestock sectors.
• Across Africa, livestock remains a critical component of economic activity and rural livelihoods. However, the region continues to face challenges related to infectious diseases, limited veterinary infrastructure, and inadequate diagnostic accessibility. These factors are creating demand for affordable, portable, and easy-to-use diagnostic solutions capable of supporting disease surveillance in resource-constrained settings.
• Increasing international support for zoonotic disease control, livestock productivity improvement, and food security programs is expected to further enhance the adoption of veterinary diagnostic technologies across the Middle East and Africa.

Veterinary Diagnostics Market Share

The market is moderately consolidated, characterized by the presence of leading global diagnostic companies alongside specialized veterinary diagnostic solution providers. Companies compete based on technological innovation, product portfolio breadth, pricing strategies, and integration of diagnostic platforms across in-clinic and reference laboratory settings, while maintaining strong distribution networks across both developed and emerging markets. Key players include IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Mars and bioMerieux, collectively accounting for a share of 70% the total market.

Market participants are increasingly focusing on expanding their product portfolios through advancements in molecular diagnostics, point-of-care testing, and AI-enabled diagnostic solutions. Strategic initiatives such as mergers, acquisitions, and partnerships particularly Mars acquisition of Heska and ongoing expansion of reference laboratory networks are intensifying competition and strengthening market positioning. Additionally, the growing emphasis on integrated diagnostic ecosystems combining instruments, consumables, and digital platforms is further driving competitive differentiation across the industry.

Veterinary Diagnostics Market Companies

Few of the prominent players operating in the veterinary diagnostics industry include:

• Agrolabo
• Bio-Rad Laboratories
• bioMerieux
• BioNote
• Biochek
• Eurolyser Diagnostica
• Fujifilm
• GD Animal Health (Royal GD)
• IDEXX Laboratories
• IDvet
• INDICAL Bioscience
• MEGACOR Diagnostik
• Mindray Animal Medical Technology
• Neogen
• QIAGEN
• Randox Laboratories
• Thermo Fisher Scientific
• Virbac
• Zoetis

• IDEXX Laboratories

IDEXX Laboratories is one of the leading players in the veterinary diagnostics market, commanding a significant share in the global market, supported by its robust in-clinic analyzers and consumables. The company continues to drive growth through innovation, including AI-powered tools like the inVue Dx analyzer and its upcoming Cancer Dx screening, while bolstering recurring revenue via its consumable ecosystem.

• Zoetis

Zoetis is engaged in the market, leveraging its strong research capabilities and strategic acquisitions to expand its diagnostic offerings. With innovative tools like blood glucose and chemistry analyzers, rapid immunoassays, and a focus on point-of-care solutions, Zoetis is enhancing diagnostic efficiency for veterinarians and driving growth in the companion animal segment.

Veterinary Diagnostics Industry News

• In June 2025, Zoetis launched AI Masses, a new AI-powered cytologic capability on its Vetscan Imagyst platform, enabling rapid in-clinic detection of potentially cancerous cells and enhancing diagnostic accuracy and workflow efficiency.
• In June 2024, IDEXX Laboratories announced the launch of the Catalyst Pancreatic Lipase Test, a new diagnostic tool designed to detect pancreatitis in dogs and cats rapidly and accurately. This test provides quantitative results in under 10 minutes at the point-of-care, enabling veterinarians to confidently diagnose or rule out pancreatitis during the patient visit and initiate timely treatment.
• In April 2023, bioMerieux and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics. This strategy will help the company to develop innovative solution in in vitro diagnostics for infectious disease detection and strengthen business relations.
• In September 2022, Zoetis Inc. acquired NewMetrica, a pioneering Scottish company that has developed state-of-the-art digital instruments. This strategy helped the company to enhance companion animal portfolio and consolidate the market position in veterinary diagnostics industry.

The veterinary diagnostics market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Consumables
• Instruments
• Software

Market, By Modality          

• Point-of-care testing (POC)
• Lab-based testing

Market, By Technology

• Clinical biochemistry 
  • Glucose monitoring
  • Blood gas and electrolyte analysis
  • Other clinical biochemistry tests        
• Immunodiagnostics 
  • Lateral flow assays
  • ELISA
  • Immunoassay analyzers
  • Other immunodiagnostic tests
• Molecular diagnostics
  • PCR
  • Microarrays
  • Other molecular diagnostic tests
• Hematology
• Urinalysis
• Diagnostic imaging (inclusive of AI assisted)
• Other technologies

Market, By Application

• Bacteriology
• Pathology
• Parasitology
• Other applications

Market, By Animal Type

• Companion animals 
  • Dogs
  • Cats
  • Horses
  • Other companion animals
• Farm animals
  • Cattle
  • Swine
  • Poultry
  • Other farm animals

Market, By End Use

• Veterinary hospitals and clinics
• Diagnostic labs
• Home care settings
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea

• Latin America
  • Brazil
  • Mexico
  • Argentina

• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE